BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35340846)

  • 1. Post-Transplant Extracorporeal Membrane Oxygenation for Severe Primary Graft Dysfunction to Support the Use of Marginal Donor Hearts.
    Shudo Y; Alassar A; Wang H; Lingala B; He H; Zhu Y; Hiesinger W; MacArthur JW; Boyd JH; Lee AM; Currie M; Woo YJ
    Transpl Int; 2022; 35():10176. PubMed ID: 35340846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant.
    Takeda K; Li B; Garan AR; Topkara VK; Han J; Colombo PC; Farr MA; Naka Y; Takayama H
    J Heart Lung Transplant; 2017 Jun; 36(6):650-656. PubMed ID: 28087104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Outcome in Severe Left Ventricular Primary Graft Dysfunction Post Cardiac Transplantation Supported by Early Use of Extracorporeal Membrane Oxygenation.
    Connolly S; Granger E; Hayward C; Huang D; Kerr S; McCanny P; Buscher H
    Transplantation; 2020 Oct; 104(10):2189-2195. PubMed ID: 31895346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case series: the outcomes, support duration, and graft function recovery after VA-ECMO use in primary graft dysfunction after heart transplantation.
    Kawabori M; Mastroianni MA; Zhan Y; Chen FY; Rastegar H; Warner KG; Reich JA; Vest A; DeNofrio D; Couper GS
    J Artif Organs; 2020 Jun; 23(2):140-146. PubMed ID: 31713054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracorporeal membrane oxygenation as a salvage therapy for patients with severe primary graft dysfunction after heart transplant.
    Jacob S; Lima B; Gonzalez-Stawinski GV; El-Sayed Ahmed MM; Patel PC; Belli EV; Makey IA; Thomas M; Landolfo K; Landolfo C; Leoni Moreno JC; Yip DS; Pham SM
    Clin Transplant; 2019 May; 33(5):e13538. PubMed ID: 30870577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of extracorporeal membrane oxygenation for early cardiac allograft dysfunction.
    Listijono DR; Watson A; Pye R; Keogh AM; Kotlyar E; Spratt P; Granger E; Dhital K; Jansz P; Macdonald PS; Hayward CS
    J Heart Lung Transplant; 2011 Jul; 30(7):783-9. PubMed ID: 21481606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of extracorporeal membrane oxygenation for heart graft dysfunction in adults: incidence, risk factors and outcomes in a multicentric study.
    Noly PE; Hébert M; Lamarche Y; Cortes JR; Mauduit M; Verhoye JP; Voisine P; Flécher E; Carrier M
    Can J Surg; 2021; 64(6):E567-E577. PubMed ID: 34728522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of primary graft dysfunction rescued by venoarterial extracorporeal membrane oxygenation after heart transplantation.
    Paulo N; Prunet H; Armoiry X; Hugon-Vallet E; Mocan R; Portran P; Sebbag L; Pozzi M; Baudry G
    Arch Cardiovasc Dis; 2022; 115(8-9):426-435. PubMed ID: 35945148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life impact of VA-ECMO due to primary graft dysfunction in patients after orthotopic heart transplantation.
    M'Pembele R; Roth S; Stroda A; Buse GL; Sixt SU; Westenfeld R; Polzin A; Rellecke P; Tudorache I; Hollmann MW; Aubin H; Akhyari P; Lichtenberg A; Huhn R; Boeken U
    ESC Heart Fail; 2022 Feb; 9(1):695-703. PubMed ID: 34734490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Intra-Aortic Balloon Pump and Extracorporeal Membrane Oxygenation in Early Graft Failure After Cardiac Transplantation.
    Loforte A; Murana G; Cefarelli M; Jafrancesco G; Sabatino M; Martin Suarez S; Pilato E; Pacini D; Grigioni F; Bartolomeo RD; Marinelli G
    Artif Organs; 2016 Aug; 40(8):E136-45. PubMed ID: 27530673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Cardiac Transplantation: Results of an A Priori Ventless Approach.
    Jorde UP; Arfaras-Melainis A; Wan N; Uehara M; Castagna F; Vukelic S; Rochlani YM; Madan SA; Murthy S; Patel SR; Sims DB; Borgi J; Goldstein DJ; Forest SJ; Jakobleff WA; Saeed O
    ASAIO J; 2024 Jan; 70(1):31-37. PubMed ID: 37797341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of groin lymphocele formation after venoarterial extracorporeal membrane oxygenation in cardiogenic shock patients.
    Salna M; Takayama H; Garan AR; Kurlansky P; Farr MA; Colombo PC; Imahiyerobo T; Morrissey N; Naka Y; Takeda K
    J Vasc Surg; 2018 Feb; 67(2):542-548. PubMed ID: 28822659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Extracorporeal Membrane Oxygenation for Primary Graft Dysfunction After Lung Transplantation.
    Takahashi T; Terada Y; Pasque MK; Nava RG; Kozower BD; Meyers BF; Patterson GA; Kreisel D; Puri V; Hachem RR
    Ann Thorac Surg; 2023 May; 115(5):1273-1280. PubMed ID: 36634836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation for primary graft dysfunction after heart transplant.
    DeRoo SC; Takayama H; Nemeth S; Garan AR; Kurlansky P; Restaino S; Colombo P; Farr M; Naka Y; Takeda K
    J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1576-1584.e3. PubMed ID: 30948318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Veno-Arterial Extracorporeal Membrane Oxygenation for Patients Undergoing Heart Transplantation: A 7-Year Experience.
    Hou JY; Li X; Yang SG; Zheng JL; Ma JF; Su Y; Zhang YJ; Guo KF; Tu GW; Luo Z
    Front Med (Lausanne); 2021; 8():774644. PubMed ID: 34988094
    [No Abstract]   [Full Text] [Related]  

  • 16. Salvage of severe primary graft dysfunction following heart transplantation using extracorporeal life support.
    Martits-Chalangari K; Hernandez O; Jamil AK; Qin H; Felius J; Jacob S; Lima B; Rafael A; Gonzalez-Stawinski GV; Sherwood MJ; Hall SA
    Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):482-486. PubMed ID: 30948987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial implications of using extracorporeal membrane oxygenation following heart transplantation.
    Krishnamoorthy B; Mehta V; Critchley W; Callan P; Shaw S; Venkateswaran R
    Interact Cardiovasc Thorac Surg; 2021 Apr; 32(4):625-631. PubMed ID: 33313866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors, and outcomes after severe primary graft dysfunction in pediatric heart transplant recipients.
    Profita EL; Gauvreau K; Rycus P; Thiagarajan R; Singh TP
    J Heart Lung Transplant; 2019 Jun; 38(6):601-608. PubMed ID: 30733156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mode of intraoperative support on primary graft dysfunction after lung transplant.
    Loor G; Huddleston S; Hartwig M; Bottiger B; Daoud D; Wei Q; Zhang Q; Ius F; Warnecke G; Villavicencio MA; Tirabassi B; Machuca TN; Van Raemdonck D; Frick AE; Neyrinck A; Toyoda Y; Kashem MA; Landeweer M; Chandrashekaran S
    J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1351-1361.e4. PubMed ID: 35236625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent association between amiodarone and severe primary graft dysfunction in orthotopic heart transplantation.
    Wright M; Takeda K; Mauro C; Jennings D; Kurlansky P; Han J; Truby L; Stein S; Topkara V; Garan AR; Yuzefpolskaya M; Colombo P; Naka Y; Farr M; Takayama H
    J Heart Lung Transplant; 2017 Nov; 36(11):1226-1233. PubMed ID: 28583372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.